Newsroom

Press Releases

Oct 6, 2021

Newly Formed Lanier Biotherapeutics Enters into License Agreement with Alloy Therapeutics

Read More

In The News

July 9, 2021

Molecular Templates, Inc. Announces Dosing of First Subject in Phase 1 Study of MT-6402 in PD-L1-Positive Solid Tumors

Read More